Best Stocks Under $20 To Buy In 2023
paymentsDiscover value opportunities among Stocklytics' Best Stocks Under $20 to Buy in 2023, offering affordable stocks with potential for growth. These picks combine affordability with potential for appreciation, catering to investors seeking options under $20 per share. Stocklytics focuses on undervalued stocks trading below $20, indicating potential for upward movement. Whether you're looking for bargain opportunities or aiming to diversify your portfolio, Stocklytics' selections offer a diverse range of stocks positioned for potential appreciation in the coming year.
| name | Price | $ Change | % Change | Market Cap | Score language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CNET CNETZW Data Action Technologies | $1.71 | $0.03 | arrow_drop_up2.08% | $3.65M | Penny Stock | 5.81K | 1.68 | Neutralremove | - | -38.75% | |||||
ADCTADC Therapeutics SA | $2.10 | -$0.20 | arrow_drop_down8.83% | $202.08M | Penny Stock | 212.18K | 2.14 | Neutralremove | - | 89.63% | |||||
CTKBCytek Biosciences | $6.65 | -$0.27 | arrow_drop_down3.90% | $891.36M | - | 212.83K | 6.77 | Neutralremove | - | -9.64% | |||||
VATEInnovate | $6.01 | -$0.02 | arrow_drop_down0.33% | $79.96M | - | 10.54K | 6.04 | Neutralremove | - | -43.30% | |||||
ARQTArcutis Biotherapeutics | $12.37 | -$0.02 | arrow_drop_down0.20% | $1.45B | - | 329.95K | 12.35 | Neutralremove | - | 452.63% | |||||
ETRNEquitrans Midstream | $12.42 | $0.00 | 0.00% | $5.42B | - | 0.00 | 24.61M | Neutralremove | 4.83% | 23.45% | |||||
SWISolarWinds | $13.55 | $0.01 | arrow_drop_up0.07% | $2.31B | - | 65.47K | 13.59 | Neutralremove | - | 13.24% | |||||
HMSTHomeStreet | $11.97 | $0.11 | arrow_drop_up0.92% | $224.97M | - | 53.42K | 12.01 | Neutralremove | - | 62.48% | |||||
HYLNHyliion Holdings | $3.25 | -$0.09 | arrow_drop_down2.68% | $582.01M | Penny Stock | 692.26K | 3.29 | Neutralremove | - | 445.77% | |||||
DNNDenison Mines | $2.24 | -$0.04 | arrow_drop_down1.96% | $2.01B | Penny Stock | 12.45M | 2.23 | Neutralremove | - | 20.69% | |||||
CDTXCidara Therapeutics | $18.61 | -$0.46 | arrow_drop_down2.45% | $203.57M | - | 13.33K | 18.66 | Neutralremove | - | 21.87% | |||||
VRAXVirax Biolabs Group Limited | $1.91 | -$0.05 | arrow_drop_down2.56% | $8.46M | Penny Stock | 35.31K | 1.94 | Neutralremove | - | -6.04% | |||||
SNPXSynaptogenix | $3.03 | -$0.09 | arrow_drop_down3.03% | $4.24M | Penny Stock | 1.70K | 3.06 | Neutralremove | - | -52.41% | |||||
STKLSunOpta | $7.63 | -$0.06 | arrow_drop_down0.84% | $901.48M | High Growth | 151.37K | 7.70 | Neutralremove | - | 47.96% | |||||
OGIOrganigram Holdings | $1.47 | -$0.04 | arrow_drop_down2.63% | $165.03M | Penny Stock | 226.99K | 1.48 | Neutralremove | - | 2.43% | |||||
PYCRPaycor HCM | $18.44 | -$0.01 | arrow_drop_down0.05% | $3.14B | - | 154.55K | 18.40 | Neutralremove | - | -16.56% | |||||
TNONTenon Medical | $2.21 | -$0.07 | arrow_drop_down3.07% | $7.15M | Penny Stock | 134.22K | 2.20 | Neutralremove | - | -85.94% | |||||
SNFCASecurity National Financial | $13.31 | -$0.11 | arrow_drop_down0.82% | $322.86M | - | 10.96K | 13.22 | Neutralremove | - | 73.67% | |||||
ACCOACCO Brands | $5.92 | -$0.20 | arrow_drop_down3.26% | $562.85M | - | 171.49K | 6.03 | Neutralremove | 5.15% | 9.51% | |||||
STAFStaffing 360 Solutions | $2.43 | -$0.03 | arrow_drop_down1.20% | $3.81M | High Growth | 82.45K | 2.49 | Neutralremove | - | -50.40% |
Showing 781-800 of 943
Results per page:
About Best Stocks Under $20 To Buy In 2023
Discover value opportunities among Stocklytics' Best Stocks Under $20 to Buy in 2023, offering affordable stocks with potential for growth. These picks combine affordability with potential for appreciation, catering to investors seeking options under $20 per share. Stocklytics focuses on undervalued stocks trading below $20, indicating potential for upward movement. Whether you're looking for bargain opportunities or aiming to diversify your portfolio, Stocklytics' selections offer a diverse range of stocks positioned for potential appreciation in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools